Jaguar Health (JAGX) Asset Utilization Ratio (2015 - 2026)
Jaguar Health (JAGX) posted quarterly Asset Utilization Ratio of 1.43 for Q1 2026, up 547.94% year-over-year from 0.22 in Q1 2025, and up 231.51% quarter-over-quarter from 0.43 in Q4 2025.
Jaguar Health (JAGX) Asset Utilization Ratio (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Asset Utilization Ratio for 12 consecutive years, with 1.43 the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 547.94% year-over-year to 1.43; the TTM figure through Mar 2026 stood at 1.43 (up 547.94% YoY), while the FY2025 annual figure was 0.4, up 78.67% from the prior year.
- Asset Utilization Ratio climbed to 1.43 in Q1 2026 per JAGX's latest filing, from 0.43 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 1.43 in Q1 2026 and bottomed at 0.06 in Q1 2022.
- Historically, Asset Utilization Ratio has averaged 0.25 across 5 years, with a median of 0.17 in 2024.
- Annual changes were most pronounced in 2023 — Asset Utilization Ratio declined 29.83% — and 2026, when it jumped 547.94%.
- Jaguar Health's Asset Utilization Ratio stood at 0.12 in 2022, then surged by 30.94% to 0.16 in 2023, then rose by 29.02% to 0.21 in 2024, then surged by 106.07% to 0.43 in 2025, then soared by 231.51% to 1.43 in 2026.
- Business Quant data shows JAGX's Asset Utilization Ratio at 1.43 in Q1 2026, 0.43 in Q4 2025, and 0.24 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.89 Bn | 131.04 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 86.05 Bn | 78.06 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 65.56 Bn | 60.38 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.46 Bn | 50.32 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 27.70 Bn | 9.30 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | 0.13 |
| 10 | Jaguar Health | 442,700.83 | -9.62 Mn | 19.11 Mn | 1.43 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.43 |
| Dec 31, 2025 | 0.43 |
| Sep 30, 2025 | 0.24 |
| Jun 30, 2025 | 0.24 |
| Mar 31, 2025 | 0.22 |
| Dec 31, 2024 | 0.21 |
| Sep 30, 2024 | 0.17 |
| Jun 30, 2024 | 0.17 |
| Mar 31, 2024 | 0.19 |
| Dec 31, 2023 | 0.16 |
| Sep 30, 2023 | 0.11 |
| Jun 30, 2023 | 0.11 |
| Mar 31, 2023 | 0.12 |
| Dec 31, 2022 | 0.12 |
| Sep 30, 2022 | 0.16 |
| Jun 30, 2022 | 0.11 |
| Mar 31, 2022 | 0.06 |
| Dec 31, 2021 | 0.08 |
| Sep 30, 2021 | 0.07 |
| Jun 30, 2021 | 0.06 |